Posts in April 4, 2024

Orio Therapeutics Secures Pre-Seed Funding

Orio Therapeutics Secures CHF 500,000 Pre-Seed Funding to Fuel the Development of Cardioprotective Therapy for Heart Attack Patients.

Monthey, Valais, Switzerland – April 4th, 2024 – Orio Therapeutics, a biotechnology company at the forefront of protein engineering for […]
by ziad.julier@oriotx.com
on Apr 4
Read more